Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of JAZZ will decline by -0.08% over the next 2 Weeks and hit $167.74 by Tuesday, February 3, 2026. In that time frame, JAZZ's share price is expected to range between $163.17 and $171.98.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Feb 3, 2026 | 163.17 | 167.74 | 171.98 |
| Feb 2, 2026 | 166.43 | 170.57 | 174.89 |
| Jan 30, 2026 | 165.83 | 169.95 | 173.90 |
| Jan 29, 2026 | 162.64 | 166.64 | 170.88 |
| Jan 28, 2026 | 165.82 | 169.80 | 173.95 |
| Jan 27, 2026 | 163.88 | 167.81 | 171.79 |
| Jan 26, 2026 | 166.64 | 170.65 | 174.94 |
| Jan 23, 2026 | 166.07 | 170.02 | 174.05 |
| Jan 22, 2026 | 162.78 | 166.71 | 170.74 |
| Jan 21, 2026 | 165.77 | 169.88 | 174.01 |
JAZZ shares rose +1.04% in Wednesday, January 21, 2026's trading session, rising from a previous close of $167.88 to move at $169.63. The stock demonstrated notable intraday movement (see JAZZ's key stats for a full breakdown), fluctuating between $167.13 and $170.45, a +1.99% trading range. While recent weeks have seen some volatility, JAZZ has managed to secure a +1.58% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 840.28K shares changing hands, 244.71K fewer than the previous session. This amounted to $142.54M in total market activity.
Will JAZZ Continue Its Upward Trend?
According to analyst ratings and projections for JAZZ, Jazz Pharmaceuticals plc shares are anticipated to increase by +1.37%, potentially reaching $171.98 per share by February 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for JAZZ. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the JAZZ stock forecast, now is a good time to buy JAZZ stock because its current trading price is +1.13% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on JAZZ covering social and institutional perspectives.
JAZZ Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into JAZZ's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 53.48% to 54.49%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 57.34%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 56.81%, maintains a neutral outlook for the long term. Insights into JAZZ's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Jazz Pharmaceuticals Short-Term Forecasts
JAZZ Forecast For Next 5 Days
Our algorithm anticipates Jazz Pharmaceuticals (JAZZ) stock could hit $148.12 by Jan 28, 2026. This represents a -12.69% rise from today's price, following a +2.57% change over the past five days.
JAZZ Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Jazz Pharmaceuticals plc (JAZZ) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $150.54, which would mean a -11.26% decrease from the current price of $169.63. Projections for this period range from a high of $177.95 to a low of $126.21.
JAZZ Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Jazz Pharmaceuticals's price over the next three months point to a drop. JAZZ stock is expected to peak at $179.52 on Apr 21, 2026 after potentially dipping to $156.67 on Jan 23, 2026. On average, JAZZ is likely to trade around $167.27 in the coming 90 days.
Jazz Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Jazz Pharmaceuticals (JAZZ) is expected to trade between $153.50 and $185.32 throughout 2026. This would result in an average price of $166.60, potentially offering investors a -1.79% return from current levels.
Jazz Pharmaceuticals plc Monthly Forecast 2026–2027
January 2026
According to our latest forecast models, Jazz Pharmaceuticals plc (JAZZ) is positioned to show a strong performance in January 2026. The price is predicted to move between $156.67 and $171.32, settling at an average of $164.13. This could translate to a -3.24% loss.
February 2026
Based on current market signals, Jazz Pharmaceuticals plc is projected to trend february 2026. We forecast a trading range from $156.82 to $175.68, with a likely average price of $166.40. Investors could expect a potential return of -1.91%.
March 2026
Our predictive algorithms indicate Jazz Pharmaceuticals plc stock may see a shift in March 2026. The expected range spans $160.34–$177.14, with an average target of $168.05. This represents a cautious outlook and a possible loss of -0.93%.
April 2026
Analyzing established trends, Jazz Pharmaceuticals plc looks set to move in April 2026. Projections place the stock between $159.36 and $179.52, averaging around $169.31. This suggests a -0.19% loss from current levels.
May 2026
Market indicators suggest Jazz Pharmaceuticals plc could experience notable changes during May 2026. Prices could fluctuate within $159.93 to $177.36, with a midpoint forecast of $169.11. The stock might deliver a -0.31% loss.
June 2026
Forecasting for June 2026, models estimate that Jazz Pharmaceuticals plc may undergo key fluctuations. If trends hold, the stock might trade between $154.37 and $177.71, averaging $166.28. This signals a cautious trajectory with potential returns around -1.98%.
July 2026
According to our latest forecast models, Jazz Pharmaceuticals plc (JAZZ) is positioned to show a strong performance in July 2026. The price is predicted to move between $155.59 and $173.75, settling at an average of $164.93. This could translate to a -2.77% loss.
August 2026
Based on current market signals, Jazz Pharmaceuticals plc is projected to trend august 2026. We forecast a trading range from $158.67 to $175.70, with a likely average price of $166.50. Investors could expect a potential return of -1.85%.
September 2026
Our predictive algorithms indicate Jazz Pharmaceuticals plc stock may see a shift in September 2026. The expected range spans $158.73–$179.41, with an average target of $167.69. This represents a cautious outlook and a possible loss of -1.15%.
October 2026
Analyzing established trends, Jazz Pharmaceuticals plc looks set to move in October 2026. Projections place the stock between $158.23 and $175.67, averaging around $167.37. This suggests a -1.33% loss from current levels.
November 2026
Market indicators suggest Jazz Pharmaceuticals plc could experience notable changes during November 2026. Prices could fluctuate within $153.50 to $185.32, with a midpoint forecast of $164.69. The stock might deliver a -2.91% loss.
December 2026
Forecasting for December 2026, models estimate that Jazz Pharmaceuticals plc may undergo key fluctuations. If trends hold, the stock might trade between $153.87 and $171.57, averaging $163.53. This signals a cautious trajectory with potential returns around -3.60%.
January 2027
According to our latest forecast models, Jazz Pharmaceuticals plc (JAZZ) is positioned to show a strong performance in January 2027. The price is predicted to move between $157.79 and $172.98, settling at an average of $165.46. This could translate to a -2.46% loss.
JAZZ's history of dividends and stock splits also plays a role in long-term investor confidence.

